Xenon Pharmaceuticals (XENE) Misses Q4 EPS by 12c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($1.31), $0.12 worse than the analyst estimate of ($1.19).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• JPMorgan Reiterates Overweight Rating on Legrand SA (LR:FP) (LGRDY) and Places on Positive Catalyst Watch
• Nomura/Instinet Upgrades MR DIY Group M Bhd (MRDIY:MK) to Buy